“We are thrilled to welcome Mike to the Caris team,” said David D. Halbert, President and CEO of Caris Life Sciences. ” His hobby of our mission, industry delight and strategic thinking will provide strong leadership as we position Caris for the next phase; expand our offer to reach with tissue and blood (measuring all coding genes) through hereditary and acquired variants, resulting in the maximum comprehensive supply that has ever existed.

“I’m thrilled to sign up for Caris at such an exciting time,” Weinstein said. “In my 25 years or older, I have noticed that few corporations with Caris’ perspective grow and replace the way we diagnose, monitor, treat and care for thousands of cancer patients each year. “